Riskpilot← Back to searchSign inGet full accessProhälsa i Falköping AB
ABActiveOrg 5564613205Fridhem SåtunaTraditional, complementary and alternative medicine activities · NACE 8696Est. 19930 employees
Revenue 2025
SEK 207K
-56% vs 2024
EBITDA margin
1.6%
-98% vs 2024
Equity ratio
73.4%
Financial strength
Net profit 2025
SEK 3K
-98% vs 2024
| Revenue | SEK 207K | -56% |
| EBITDA | SEK 3K | -98% |
| Net profit | SEK 3K | -98% |
| Total assets | SEK 486K | +3% |
| Equity | SEK 357K | -20% |
| Employees | 0 | — |
Legal name
Prohälsa i Falköping AB
Org number
5564613205
Legal form
Aktiebolag
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
1 februari 1993
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva akupunktur, traditionell kinesisk medicin och örtmedicin, skönhets- och friskvård, försäljning av hälsoprodukter och hälsokost, utbildning och föredragsverksamhet, försäljning av litteratur, fastighetsförvaltning, personlig coachning och trädgårdskötsel.
Address
Fridhem Såtuna
Phone
+4651321890
Email
janwinbo.prohalsa@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 927 | 781 | 467 | 471 | 207 |
| Staff expenses | — | −336 | −445 | −80 | −51 |
| EBITDA | −12 | 157 | −199 | 185 | 3 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −12 | 157 | −199 | 185 | 3 |
| Net financials | 1 | −1 | 0 | 1 | −0 |
| Profit before tax | −10 | 156 | −199 | 186 | 3 |
| Tax | −0 | — | — | — | — |
| Net profit | −10 | 156 | −199 | 186 | 3 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 634 | 484 | 335 | 472 | 486 |
| Equity | 300 | 456 | 257 | 444 | 357 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 334 | 28 | 78 | 28 | 130 |
| Total debt | 334 | 28 | 78 | 28 | 130 |
EBITDA margin
1.6%
This company
15.8%
Market median
-90% vs market
20212025
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
20212025
Return on equity
0.9%
This company
18.4%
Market median
-95% vs market
20212025
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
20212025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20212025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Prohälsa i Falköping AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stina Vera Christina Charlotte Norbye | Deputy Board Member | 0 companies |
| Jan Olle Winbo | Board of Directors | 0 companies |
| Sven Ingemar Styrud | Deputy Board Member | 0 companies |